Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone

US9988656B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9988656-B2
Application numberUS-201514954487-A
CountryUS
Kind codeB2
Filing dateNov 30, 2015
Priority dateNov 25, 2009
Publication dateJun 5, 2018
Grant dateJun 5, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring microbial organism comprising exogenous nucleic acids encoding a combination of enzymes of: a 4-hydroxybutyrate dehydrogenase; a 4-hydroxybutyryl-CoA transferase; a 4-hydroxybutyryl-CoA reductase (aldehyde forming); a 1,4-butanediol dehydrogenase; and a 4-hydroxybutyrate lactonase; wherein the exogenous nucleic acids are expressed in the microbial organism. 2. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism further comprises exogenous nucleic acids encoding a second combination of enzymes selective from the group consisting of: (a) a succinyl-CoA transferase, a succinyl-CoA hydrolase, or a succinyl-CoA synthetase; and a succinyl-CoA reductase (aldehyde forming); (b) an alpha-ketoglutarate decarboxylase; and (c) a glutamate dehydrogenase or glutamate transaminase; a glutamate decarboxylase; and a 4-aminobutyrate dehydrogenase or a 4-aminobutyrate transaminase, wherein the exogenous nucleic acids encoding the second combination of enzymes are expressed in the microbial organism. 3. The non-naturally occurring microbial organism of claim 1 , wherein at least one, two, three, four or five of the exogenous nucleic acids is a heterologous encoding nucleic acid. 4. The non-naturally occurring microbial organism of claim 1 , wherein the exogenous nucleic acids are heterologous encoding nucleic acids. 5. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism is a bacterium, yeast or fungus. 6. The non-naturally occurring microbial organism of claim 5 , wherein the bacterium is selected from the group consisting of Escherichia coli, Klebsiella oxytoca, Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes, Mannheimia succiniciproducens, Rhizobium etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens , and Pseudomonas putida. 7. The non-naturally occurring microbial organism of claim 5 , wherein the yeast or fungus is selected from the group consisting of Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Aspergillus terreus, Aspergillus niger, Pichia pastoris, Rhizopus arrhizus , and Rhizobus oryzae. 8. A composition comprising the non-naturally occurring microbial organism of claim 1 in a substantially anaerobic culture medium.

Assignees

Inventors

Classifications

  • Genes encoding for enzymes or proenzymes · CPC title

  • polyhydric · CPC title

  • Bacteria; Culture media therefor · CPC title

  • C12P17/04Primary

    containing a five-membered hetero ring, e.g. griseofulvin {, vitamin C} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9988656B2 cover?
The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.
Who is the assignee on this patent?
Genomatica Inc
What technology area does this patent fall under?
Primary CPC classification C12P17/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).